Cancer BiologybioRxivPreprint
A multimodal precision oncology platform integrating genomics,single-cell transcriptomics, and functional drug screening expandstherapeutic options in pediatric brain tumors
DOI 10.64898/2026.10.12.758619
Author
Samuel Henry Cheshier
Intermountain HealthcareORCID 0000-0003-4983-6610Unclaimed ORCID profile · follow to get notified of new preprints
Biology Disciplines
Click to filter author papersSignature Assays, Organisms & Methods
Click to filter · or open tagActivity by Year
2025-2026 · peak 4/yrCo-Author Collaboration Network
10 top collaborators · 21 mutual co-author linksFocal author (center)Selected co-authorORCID co-authorUnlinked name
Curved chords = mutual co-authorship5 papers
Recent·Most cited
- BioinformaticsbioRxivPreprint
DS5: An Open-Source Framework for Standardized High-Throughput Drug Screening Data Storage, Analysis, and Drug Prioritization
Hui Yang, James Lubkowitz, Gabor Marth…·義行 高橋
DS5 is an open-source framework that standardizes HTS data storage, analysis, and drug prioritization, validated against public benchmarks and applied in clinical settings.
DOI 10.64898/2026.09.22.753533 - Cancer BiologybioRxivPreprint
NG2-targeting macrophages inhibit 3D invasion of patient-derived glioblastoma spheroids
Elena Kurudza, Sophia R.S. Varady, Daniel Greiner…·Minna Roh‐Johnson
This study shows NG2-targeting CAR-Ms engulf glioblastoma cells and block over 85% of their 3D invasion.
DOI 10.64898/2026.04.03.715398 - BioengineeringbioRxivPreprint
Positron Emission Tomography of CD47/SIRPα Axis and Image-Informed Therapeutic Design
Esther Need, Neetu Singh, Ayden Berndt…·Sixiang Shi
The paper develops radiotracers for CD47/SIRPα axis imaging and evaluates their biodistribution in mice, showing potential for optimizing therapeutic strategies.
- Cancer BiologyOncogenePeer-reviewed
CSPG4-targeting CAR-macrophages inhibit melanoma growth
Daniel Greiner, Qian Xue, Trinity Q Alaka’i Waddell…·Minna Roh‐Johnson
This study engineers CSPG4-targeting CAR-macrophages that inhibit melanoma growth in vitro and in vivo, showing promise for solid tumor immunotherapy.
35 citationstop 1%